Deborah Dunsire
Net worth: 603 554 $ as of 2026-09-29
Net worth: 603 554 $ as of 2026-09-29
Currently, Deborah L. Dunsire is President & Chief Executive Officer for H. Lundbeck A. She is also Secretary at Biotechnology Innovation Organization and on the board of 6 other companies. In her past career Dr. Dunsire held the position of President, Chief Executive Officer & Director at FORUM Pharmaceuticals, Inc., President, Chief Executive Officer & Director at XTuit Pharmaceuticals, Inc., Vice President-Oncology Business Unit at Novartis AG and Senior Vice President-North America Oncology at Novartis Oncology, Inc. (a subsidiary of Novartis AG) and Director at Takeda Pharmaceutical Co., Ltd. and President, Chief Executive Officer & Director at Millennium Pharmaceuticals, Inc. (a subsidiary of Takeda Pharmaceutical Co., Ltd.). Dr. Dunsire received a graduate degree from the University of the Witwatersrand.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-13 | 38,566 ( 0.04% ) | 579 647 $ | 2026-09-29 | |
| 2026-07-21 | 28 ( 0% ) | 23 907 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 2017-04-05 |
| MCKESSON CORPORATION | Director/Board Member | 2024-06-02 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Secretary | 2015-06-14 |
Gabrielle's Angel Foundation | Director/Board Member | - |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Director/Board Member | 2010-03-18 |
Gabrielle's Angel Foundation for Cancer Research, Inc.
Gabrielle's Angel Foundation for Cancer Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a scientific research organization to improve treatment against leukemia related cancers | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director/Board Member | 2024-11-14 |
| H. LUNDBECK A/S | Chief Executive Officer | 2023-09-30 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 2021-07-13 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 20 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
McKesson Corp.
McKesson Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical supplies & provides related technology services | Distribution Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Massachusetts General Physician's Organization, Inc.
Massachusetts General Physician's Organization, Inc. Medical/Nursing ServicesHealth Services Operates as a multi-specialty medical firm | Health Services |
Gabrielle's Angel Foundation for Cancer Research, Inc.
Gabrielle's Angel Foundation for Cancer Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a scientific research organization to improve treatment against leukemia related cancers | Commercial Services |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Gabrielle's Angel Foundation |
Select your edition
All financial news and data tailored to specific country editions